Profile data is unavailable for this security.
About the company
Joinn Laboratories China Co Ltd is a China-based company primarily engaged in the pharmacology and toxicology research of new drugs. Non-clinical research services include drug safety evaluation, pharmacokinetic research as well as pharmacological and pharmacodynamic research. Clinical trials and related services include clinical contract research organization services, phase I clinical research collaboration unit (CRU), and bioanalysis services. Experimental model business mainly includes rodents and non-human primates. The Company conducts its businesses both in the domestic market and overseas markets.
- Revenue in HKD (TTM)2.38bn
- Net income in HKD146.76m
- Incorporated1998
- Employees2.59k
- LocationJoinn Laboratories China Co LtdA5 Rongjing East StreetEconomic-Technological Development AreaBEIJING 100176ChinaCHN
- Phone+86 1 067869582
- Fax+86 1 067869966
- Websitehttps://www.joinnlabs.com/
More ▼
27.36%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Brown Brothers Harriman & Co. (Investment Management)as of 05 Mar 2024 | 5.73m | 4.82% |
| UBS Asset Management (Hong Kong) Ltd.as of 09 Oct 2024 | 5.45m | 4.58% |
| The Vanguard Group, Inc.as of 06 Nov 2024 | 3.80m | 3.20% |
| FIL Investment Management (Singapore) Ltd.as of 06 Mar 2024 | 3.67m | 3.08% |
| FIL Investment Management (Hong Kong) Ltd.as of 06 Mar 2024 | 3.36m | 2.82% |
| abrdn Investment Management Ltd.as of 15 Mar 2024 | 3.31m | 2.78% |
| UBS SDIC Fund Management Co., Ltd.as of 30 Jun 2024 | 2.44m | 2.05% |
| Abrdn Asia Ltd.as of 15 Mar 2024 | 1.78m | 1.49% |
| GF Fund Management Co., Ltd.as of 30 Jun 2024 | 1.52m | 1.28% |
| BlackRock Advisors (UK) Ltd.as of 24 Apr 2023 | 1.51m | 1.27% |
More ▼
Data from 30 Jun 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
